Zacks downgraded shares of Idera Pharmaceuticals (NASDAQ:IDRA) to a neutral rating in a report issued on Thursday, AnalystRatings.NET reports. They currently have $6.10 target price on the stock. Idera Pharmaceuticals Inc. (NASDAQ:IDRA) stock opened at $5.62 in last session, and closed at $5.78, while the day range of Idera Pharmaceuticals Inc. (NASDAQ:IDRA) stock is $5.25 – $5.85. The stock showed a positive weekly performance of -0.17%.
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare rare diseases, announced that on March 3, 2014, Aegerion granted stock options to purchase an aggregate of 51,750 shares of common stock to 16 new employees under the inducement stock option program described below. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) stock opened at $50.15 in last session, and closed at $55.53 by gaining 10.60%. The 52 week range of $35.24 – $101.00. Company’s market capitalization is $1.63 billion.
Crosstex Energy Inc. will triple in size and become a more proactive builder of pipelines and other critically needed infrastructure after stockholders approve the oil and gas company’s merger with Devon Energy Corp. Crosstex Energy Inc. (NASDAQ:XTXI) stock decreased -4.57% and finished the last session at $37.60. The EPS of the stock remained -0.52. Company’s market capitalization is $1.79 billion.
InterMune Inc. (NASDAQ:ITMN) gained Friday after Reuters reported the company is attracting takeover interest. In the view of Wells Fargo analyst Brian Abrahams, the possibility is realistic. InterMune Inc. (NASDAQ:ITMN) stock opened the session at $30.83, and closed the session at $33.87. The 52 week range of the InterMune Inc. (NASDAQ:ITMN) stock remained $8.61 – $38.73 and the day range was $29.97 – $35.58.
Leave a Reply